Habeos IG - Search Results

1

Ziros PG, Habeos IG, Chartoumpekis DV, Ntalampyra E, Somm E, Renaud CO, Bongiovanni M, Trougakos IP, Yamamoto M, Kensler TW, Santisteban P, Carrasco N, Ris-Stalpers C, Amendola E, Liao XH, Rossich L, Thomasz L, Juvenal GJ, Refetoff S, Sykiotis GP. Ziros PG, et al. Among authors: habeos ig. Thyroid. 2018 Jun;28(6):780-798. doi: 10.1089/thy.2018.0018. Thyroid. 2018. PMID: 29742982 Free PMC article.

2

The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells.

Ziros PG, Gil AP, Georgakopoulos T, Habeos I, Kletsas D, Basdra EK, Papavassiliou AG. Ziros PG, et al. J Biol Chem. 2002 Jun 28;277(26):23934-41. doi: 10.1074/jbc.M109881200. Epub 2002 Apr 17. J Biol Chem. 2002. PMID: 11960980 Free article.

3

Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.

Ziros PG, Georgakopoulos T, Habeos I, Basdra EK, Papavassiliou AG. Ziros PG, et al. J Bone Miner Res. 2004 Nov;19(11):1892-904. doi: 10.1359/JBMR.040701. Epub 2004 Jul 7. J Bone Miner Res. 2004. PMID: 15476590 Free article.

4

Statins and transcriptional regulation: the FXR connection.

Habeos I, Ziros PG, Psyrogiannis A, Vagenakis AG, Papavassiliou AG. Habeos I, et al. Biochem Biophys Res Commun. 2005 Aug 26;334(2):601-5. doi: 10.1016/j.bbrc.2005.06.129. Biochem Biophys Res Commun. 2005. PMID: 16009343

5

Thyroid function in humans with morbid obesity.

Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE, Kyriazopoulou VE. Michalaki MA, et al. Among authors: habeos ig. Thyroid. 2006 Jan;16(1):73-8. doi: 10.1089/thy.2006.16.73. Thyroid. 2006. PMID: 16487017

6

Fibrocalculous pancreatic diabetes in patient residing in the Mediterranean region.

Habeos I, Kyriazopoulou V, Chartoumpekis D, Psyrogiannis A. Habeos I, et al. Hormones (Athens). 2006 Jan-Mar;5(1):64-6. doi: 10.14310/horm.2002.11170. Hormones (Athens). 2006. PMID: 16749187 Free article.

7

Calciphylaxis: a complication of end-stage renal disease improved by parathyroidectomy.

Maroulis JC, Fourtounas C, Vlachojannis JG, Siasos N, Karavias D, Chartoumpekis D, Habeos I. Maroulis JC, et al. Hormones (Athens). 2006 Jul-Sep;5(3):210-3. doi: 10.14310/horm.2002.11184. Hormones (Athens). 2006. PMID: 16950756 Free article.

8

Simvastatin activates Keap1/Nrf2 signaling in rat liver.

Habeos IG, Ziros PG, Chartoumpekis D, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG. Habeos IG, et al. J Mol Med (Berl). 2008 Nov;86(11):1279-85. doi: 10.1007/s00109-008-0393-4. Epub 2008 Sep 2. J Mol Med (Berl). 2008. PMID: 18787804

9

Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway.

Chartoumpekis D, Ziros PG, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG, Habeos IG. Chartoumpekis D, et al. Among authors: habeos ig. Biochem Biophys Res Commun. 2010 May 28;396(2):463-6. doi: 10.1016/j.bbrc.2010.04.117. Epub 2010 Apr 24. Biochem Biophys Res Commun. 2010. PMID: 20417615

10

The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation.

Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D. Sykiotis GP, et al. Among authors: habeos ig. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):41-8. doi: 10.1097/MCO.0b013e32834136f2. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21102319 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page